A Randomized, Double-Blinded, Adaptive Phase 2 Study to Evaluate the Safety and Efficacy of IV or IV/PO Omadacycline and IV/PO Levofloxacin in the Treatment of Adults With Acute Pyelonephritis
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2019
At a glance
- Drugs Omadacycline (Primary) ; Omadacycline (Primary) ; Levofloxacin; Levofloxacin
- Indications Pyelonephritis
- Focus Therapeutic Use
- Sponsors Paratek Pharmaceuticals
- 29 Nov 2018 Status changed from not yet recruiting to recruiting.
- 27 Nov 2018 According to Paratek Pharmaceuticals media release, data from this study Topline data from this study is also expected in the second half of 2019.
- 27 Nov 2018 According to Paratek Pharmaceuticals media release, Paratek Pharmaceuticals Doses First Patient in this study.